These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20339089)

  • 41. A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.
    Feys T; Poppe B; De Preter K; Van Roy N; Verhasselt B; De Paepe P; De Paepe A; Speleman F
    Haematologica; 2007 Jul; 92(7):913-20. PubMed ID: 17606441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Composite mantle-cell lymphoma and classical Hodgkin lymphoma.
    Hayes SJ; Banerjee SS; Cook Y; Houghton JB; Menasce LP
    Histopathology; 2006 Apr; 48(5):621-3. PubMed ID: 16623796
    [No Abstract]   [Full Text] [Related]  

  • 43. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
    Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
    Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma.
    Schwarzer R; Jundt F
    Curr Mol Med; 2011 Apr; 11(3):236-45. PubMed ID: 21375490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA.
    Buedts L; Wlodarska I; Finalet-Ferreiro J; Gheysens O; Dehaspe L; Tousseyn T; Fornecker LM; Lazarovici J; Casasnovas RO; Gac AC; Bonnet C; Bouabdallah K; Copie-Bergman C; Fabiani B; Dierickx D; Marcelis L; Vermeesch J; André M; Vandenberghe P
    Blood Adv; 2021 Apr; 5(7):1991-2002. PubMed ID: 33843986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed-Sternberg (HRS) cells: high expression of interleukin-11 receptor alpha.
    Karube K; Ohshima K; Suzumiya J; Kawano R; Kikuchi M; Harada M
    Ann Oncol; 2006 Jan; 17(1):110-6. PubMed ID: 16291580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies.
    Küpper M; Joos S; von Bonin F; Daus H; Pfreundschuh M; Lichter P; Trümper L
    Br J Haematol; 2001 Mar; 112(3):768-75. PubMed ID: 11260082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs.
    Kashkar H; Deggerich A; Seeger JM; Yazdanpanah B; Wiegmann K; Haubert D; Pongratz C; Krönke M
    Blood; 2007 May; 109(9):3982-8. PubMed ID: 17185461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell-Specific Long Noncoding RNAs.
    Tayari MM; Winkle M; Kortman G; Sietzema J; de Jong D; Terpstra M; Mestdagh P; Kroese FG; Visser L; Diepstra A; Kok K; van den Berg A; Kluiver J
    Am J Pathol; 2016 Sep; 186(9):2462-72. PubMed ID: 27423697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
    Roemer MGM; Redd RA; Cader FZ; Pak CJ; Abdelrahman S; Ouyang J; Sasse S; Younes A; Fanale M; Santoro A; Zinzani PL; Timmerman J; Collins GP; Ramchandren R; Cohen JB; De Boer JP; Kuruvilla J; Savage KJ; Trneny M; Ansell S; Kato K; Farsaci B; Sumbul A; Armand P; Neuberg DS; Pinkus GS; Ligon AH; Rodig SJ; Shipp MA
    J Clin Oncol; 2018 Apr; 36(10):942-950. PubMed ID: 29394125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
    Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
    Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PKCeta expression contributes to the resistance of Hodgkin's lymphoma cell lines to apoptosis.
    Abu-Ghanem S; Oberkovitz G; Benharroch D; Gopas J; Livneh E
    Cancer Biol Ther; 2007 Sep; 6(9):1375-80. PubMed ID: 17786031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
    Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
    Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
    Chetaille B; Bertucci F; Finetti P; Esterni B; Stamatoullas A; Picquenot JM; Copin MC; Morschhauser F; Casasnovas O; Petrella T; Molina T; Vekhoff A; Feugier P; Bouabdallah R; Birnbaum D; Olive D; Xerri L
    Blood; 2009 Mar; 113(12):2765-3775. PubMed ID: 19096012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.
    Wienand K; Chapuy B; Stewart C; Dunford AJ; Wu D; Kim J; Kamburov A; Wood TR; Cader FZ; Ducar MD; Thorner AR; Nag A; Heubeck AT; Buonopane MJ; Redd RA; Bojarczuk K; Lawton LN; Armand P; Rodig SJ; Fromm JR; Getz G; Shipp MA
    Blood Adv; 2019 Dec; 3(23):4065-4080. PubMed ID: 31816062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosome 16q deletion and loss of E-cadherin expression in Hodgkin and Reed-Sternberg cells.
    Ohshima K; Haraoka S; Yoshioka S; Kawasaki C; Tutiya T; Suzumiya J; Kikuchi M
    Int J Cancer; 2001 Jun; 92(5):678-82. PubMed ID: 11340571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues.
    Juskevicius D; Jucker D; Dietsche T; Perrina V; Rufle A; Ruiz C; Dirnhofer S; Tzankov A
    Lab Invest; 2018 Nov; 98(11):1487-1499. PubMed ID: 30087457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal relationship of classical hodgkin lymphoma and its recurrences.
    Obermann EC; Mueller N; Rufle A; Menter T; Mueller-Garamvoelgyi E; Cathomas G; Dirnhofer S; Tzankov A
    Clin Cancer Res; 2011 Aug; 17(16):5268-74. PubMed ID: 21737506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.